Calreticulin del52 and ins5 knock-in mice recapitulate different myeloproliferative phenotypes observed in patients with MPN

Archive ouverte

Benlabiod, Camélia | Cacemiro, Maira da Costa | Nédélec, Audrey | Edmond, Valérie | Muller, Delphine | Rameau, Philippe | Touchard, Laure | Gonin, Patrick | Constantinescu, Stefan | Raslova, Hana | Villeval, Jean-Luc | Vainchenker, William | Plo, Isabelle | Marty, Caroline

Edité par CCSD ; Nature Publishing Group -

International audience. Abstract Somatic mutations in the calreticulin ( CALR ) gene are associated with approximately 30% of essential thrombocythemia (ET) and primary myelofibrosis (PMF). CALR mutations, including the two most frequent 52 bp deletion ( del52 ) and 5 bp insertion ( ins5 ), induce a frameshift to the same alternative reading frame generating new C-terminal tails. In patients, del52 and ins5 induce two phenotypically distinct myeloproliferative neoplasms (MPNs). They are equally found in ET, but del52 is more frequent in PMF. We generated heterozygous and homozygous conditional inducible knock-in (KI) mice expressing a chimeric murine CALR del52 or ins5 with the human mutated C-terminal tail to investigate their pathogenic effects on hematopoiesis. Del52 induces greater phenotypic changes than ins5 including thrombocytosis, leukocytosis, splenomegaly, bone marrow hypocellularity, megakaryocytic lineage amplification, expansion and competitive advantage of the hematopoietic stem cell compartment. Homozygosity amplifies these features, suggesting a distinct contribution of homozygous clones to human MPNs. Moreover, homozygous del52 KI mice display features of a penetrant myelofibrosis-like disorder with extramedullary hematopoiesis linked to splenomegaly, megakaryocyte hyperplasia and the presence of reticulin fibers. Overall, modeling del52 and ins5 mutations in mice successfully recapitulates the differences in phenotypes observed in patients.

Consulter en ligne

Suggestions

Du même auteur

Rare type 1-like and type 2-like calreticulin mutants induce similar myeloproliferative neoplasms as prevalent type 1 and 2 mutants in mice

Archive ouverte | Toppaldoddi, Katte Rao | CCSD

International audience

SRSF2-P95H decreases JAK/STAT signaling in hematopoietic cells and delays myelofibrosis development in mice

Archive ouverte | Willekens, Christophe | CCSD

International audience

Different impact of calreticulin mutations on human hematopoiesis in myeloproliferative neoplasms

Archive ouverte | El-Khoury, Mira | CCSD

International audience

Chargement des enrichissements...